Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 3, Open-Label Trial of Sipuleucel-T Administered To Patients On Active Surveillance For Newly Diagnosed Prostate Cancer

NCT03686683 is registered in ClinicalTrials.gov with Dendreon as lead sponsor.

NCT NCT03686683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03686683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 3, Open-Label Trial of Sipuleucel-T Administered To Patients On Active Surveillance For Newly Diagnosed Prostate Cancer
Lead sponsor
Dendreon
Phase
Phase 3
Overall status
Completed
Start date
October 18, 2018
Completion date
March 10, 2023
Enrollment
532 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the prostate